Piramal drops on profit booking

Image
Capital Market
Last Updated : May 16 2017 | 12:01 PM IST

Piramal Enterprises fell 1.85% to Rs 2,812.95 at 11:45 IST on BSE, with the stock sliding on profit booking after a recent strong rally.

Meanwhile, the S&P BSE Sensex was up 111.35 points or 0.37% at 30,433.47.

On the BSE, 27,000 shares were traded on the counter so far as against the average daily volumes of 23,654 shares in the past one quarter. The stock had hit a high of Rs 2,910 and a low of Rs 2,797.15 so far during the day.

The stock had hit a record high of Rs 2,941.90 on 15 May 2017 and a 52-week low of Rs 1,215 on 13 May 2016. It had outperformed the market over the past one month till 15 May 2017, advancing 28.09% compared with the Sensex's 2.92% rise. The scrip had also outperformed the market over the past one quarter, gaining 54.39% as against the Sensex's 7.69% rise.

The large-cap company has equity capital of Rs 34.51 crore. Face value per share is Rs 2.

Shares of Piramal Enterprises had surged 15.1% in the preceding four trading sessions to settle at Rs 2,866.10 yesterday, 15 May 2017, from its closing of Rs 2,490.15 on 9 May 2017. The stock surged 9.84% in a single trading session yesterday, 15 May 2017 after the company reported strong Q4 March 2017 earnings after market hours on Friday, 12 May 2017.

Piramal Enterprises' consolidated net profit rose 61.1% to Rs 310.96 crore on 45.8% rise in net sales to Rs 2450.93 crore in Q4 March 2017 over Q4 March 2016. The strong profitability was mainly on account of improved performance across business segments and lower research and development (R&D) expenses.

The company's total loan book grew by 87% to Rs 24400 crore in the year ended March 2017 compared with Rs 13048 crore in the year ended March 2016.

On consolidated basis, the company's net profit rose 38.4% to Rs 1252.33 crore on 34.1% rise in net sales to Rs 8503.65 crore in the year ended March 2017 over the year ended March 2016.

Piramal Enterprises is one of the India's large diversified companies, with a presence in pharmaceuticals, healthcare information management and financial services.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 16 2017 | 11:46 AM IST

Next Story